» Authors » Guzhalinuer Abulizi

Guzhalinuer Abulizi

Explore the profile of Guzhalinuer Abulizi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 16
Citations 143
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Wu X, Sun Y, Yang H, Wang J, Lou H, Li D, et al.
Lancet . 2024 Oct; 404(10463):1668-1676. PMID: 39426385
Background: Cadonilimab is a bispecific antibody targeting PD-1 and CTLA-4, which has shown substantial clinical benefits in advanced cervical cancer. In the COMPASSION-16 trial, we aimed to evaluate the addition...
2.
Wu X, Zhu J, Yin R, Yang J, Liu J, Wang J, et al.
EClinicalMedicine . 2024 May; 72:102629. PMID: 38745967
Background: Niraparib significantly prolonged progression-free survival versus placebo in patients with platinum-sensitive, recurrent ovarian cancer (PSROC), regardless of germline mutation (gm) status, in NORA. This analysis reports final data on...
3.
Wu A, Xue P, Abulizi G, Tuerxun D, Rezhake R, Qiao Y
Front Med (Lausanne) . 2023 Apr; 10:1060451. PMID: 37056736
Introduction: Well-trained colposcopists are in huge shortage worldwide, especially in low-resource areas. Here, we aimed to evaluate the Colposcopic Artificial Intelligence Auxiliary Diagnostic System (CAIADS) to detect abnormalities based on...
4.
Dang L, Kong L, Zhao Y, Dai Y, Ma L, Wei L, et al.
Chin J Cancer Res . 2022 Nov; 34(5):496-509. PMID: 36398123
Objective: We aimed to evaluate the effectiveness of different triage strategies for high-risk human papillomavirus (hrHPV)-positive women in primary healthcare settings in China. Methods: This study was undertaken in 11...
5.
Abulizi G, Mijiti P, Naizhaer G, Tuerxun G, Abuduxikuer G, Zhang Y, et al.
Cancer Med . 2021 Nov; 10(24):9022-9029. PMID: 34816621
Background: The careHPV test as a primary screening method for cervical cancer has been proven to be the best option for Uyghur women in Xinjiang in a previous study. In...
6.
Zhang J, Zhao Y, Dai Y, Dang L, Ma L, Yang C, et al.
JAMA Oncol . 2020 Dec; 7(2):263-270. PMID: 33377903
Importance: Evidence is needed regarding the introduction of high-risk human papillomavirus (hrHPV) testing into China's national cervical cancer screening program. Objective: To evaluate hrHPV testing as a new screening modality...
7.
Naizhaer G, Yuan J, Mijiti P, Aierken K, Abulizi G, Qiao Y
Medicine (Baltimore) . 2020 Feb; 99(6):e19135. PMID: 32028440
This study is to evaluate the screening methods of cervical cancers for rural females in Kash bachu, Xinjiang, China.A total number of 3000 married females were surveyed, and subjected to...
8.
Abudurexiti G, Tuerxun G, Abulizi G, Mijiti P, Aierken K, Maimaiti A, et al.
J Low Genit Tract Dis . 2019 Nov; 24(1):34-37. PMID: 31725049
Objective: The aim of the study was to determine an appropriate follow-up schedule for human papillomavirus (HPV) detection by evaluating the clearance time of HPV after treatment. Materials And Methods:...
9.
Yuan M, Yao L, Abulizi G
Medicine (Baltimore) . 2019 Oct; 98(38):e17225. PMID: 31567982
The present study is to analyze the difference of gene methylation in early cervical adenocarcinoma and to find molecular markers for predicting the occurrence and development of cervical adenocarcinoma.A total...
10.
Aierken K, Dong Z, Abulimiti T, Zhang Y, Abuduxikuer G, Tuerxun G, et al.
Mol Genet Genomic Med . 2019 Mar; 7(5):e626. PMID: 30829464
Aims: Cyclin dependent kinase 6 (CDK6) plays a crucial role in malignant tumor whereas less is reported in cervical cancer development. The aim of this study was to evaluate the...